Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 류동열 | * |
dc.date.accessioned | 2019-01-24T16:30:15Z | - |
dc.date.available | 2019-01-24T16:30:15Z | - |
dc.date.issued | 2019 | * |
dc.identifier.issn | 1320-5358 | * |
dc.identifier.other | OAK-24124 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/248259 | - |
dc.description.abstract | Aim: Although a National Health Screening Program (NHSP) for chronic kidney disease (CKD) has been implemented in Korea since 2002, its cost-effectiveness has never been determined. This study aimed to estimate the cost-utility of NHSP for CKD in Korea. Methods: A Markov decision analytic model was constructed to compare CKD screening strategies of the NHSP with no screening. We developed a model that simulated disease progression in a cohort aged 20–120 years or death from the societal perspective. Results: Biannual screening starting at age 40 for CKD by proteinuria (dipstick) and estimated glomerular filtration ratio had an ICUR of $66 874/QALY relative to no screening. The targeted screening strategy had an ICUR of $37 812/QALY and $40 787/QALY for persons with diabetes and hypertension, respectively. ICURs improved with lower cost strategies. The most influential parameter that might make screening more cost-effective was the effectiveness of treatment on CKD to decrease disease progression and mortality. Conclusions: The Korean NHSP for CKD is more cost-effective for patients with diabetes or hypertension than the general population, consistent with prior studies. Although it is too early to conclude the cost-effectiveness of the Korean NHSP for CKD, this study provides evidence that is useful in evaluating the cost-effectiveness of CKD interventions. © 2017 Asian Pacific Society of Nephrology | * |
dc.language | English | * |
dc.publisher | Blackwell Publishing | * |
dc.subject | chronic kidney disease | * |
dc.subject | cost-effectiveness | * |
dc.subject | cost-utility analysis | * |
dc.subject | screening | * |
dc.title | Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea | * |
dc.type | Article | * |
dc.relation.issue | 1 | * |
dc.relation.volume | 24 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 56 | * |
dc.relation.lastpage | 64 | * |
dc.relation.journaltitle | Nephrology | * |
dc.identifier.doi | 10.1111/nep.13203 | * |
dc.identifier.wosid | WOS:000453551600008 | * |
dc.identifier.scopusid | 2-s2.0-85058705075 | * |
dc.author.google | Go D.-S. | * |
dc.author.google | Kim S.-H. | * |
dc.author.google | Park J. | * |
dc.author.google | Ryu D.-R. | * |
dc.author.google | Lee H.-J. | * |
dc.author.google | Jo M.-W. | * |
dc.contributor.scopusid | 류동열(7103144218;56997547400;56669926200) | * |
dc.date.modifydate | 20240123102517 | * |